The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation
Open accessAbstract
Replicated international studies have underscored the human and societal costs associated with major depressive disorder. Despite the proven efficacy of monoamine-based antidepressants in major depression, the majority of treated individuals fail to achieve full syndromal and functional recovery with the index and subsequent pharmacological treatments. Ketamine and esketamine represent pharmacologically novel treatment avenues for adults with treatment-resistant depression. In addition to providing hope to affected persons, these agents represent the first non-monoaminergic agents with proven rapid-onset efficacy in major depressive disorder. Nevertheless, concerns remain about the safety and tolerability of ketamine and esketamine in mood disorders. Moreover, there is uncertainty about the appropriate position of these agents in treatment algorithms, their comparative effectiveness, and the appropriate setting, infrastructure, and personnel required for their competent and safe implementation. In this article, an international group of mood disorder experts provides a synthesis of the literature with respect to the efficacy, safety, and tolerability of ketamine and esketamine in adults with treatment-resistant depression. The authors also provide guidance for the implementation of these agents in clinical practice, with particular attention to practice parameters at point of care. Areas of consensus and future research vistas are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Available evidence also indicates that the efficacy of ketamine/esketamine in the acute treat ment of TRD is also apparent in individuals with greater de grees of antidepressant resistance 205 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [205]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The risks for the foregoing safety concerns would be expected to be mitigated when administering ketamine/esketamine under medical supervision in accordance with best practices 205 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [205]
In the citing paper
“This result is in line with a recent review of literature emphasising that tolerance of ketamine is good.32”
From Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trial (2022) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants
Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016) · Nature Medicine · doi:10.1038/nm.4050 · Cited by 1,750
Self-citationSynaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Zanos, P., Moaddel, R., Morris, P. J., Georgiou, P., Fischell, J., Elmer, G. I., Alkondon, M., Yuan, P., Pribut, H. J., Singh, N. S., et al. (2016) · Nature · doi:10.1038/nature17998 · Cited by 1,609
Self-citationKetamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260
Self-citationMechanisms of ketamine action as an antidepressant
Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127
Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103
Self-citationMcIntyre, R. S., Berk, M., Brietzke, E., Goldstein, B. I., López-Jaramillo, C., Kessing, L. V., Malhi, G. S., Nierenberg, A. A., Rosenblat, J. D., Majeed, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31544-0 · Cited by 1,047
Self-citationDiazgranados, N., Ibrahim, L., Brutsche, N. E., Newberg, A., Kronstein, P., Khalife, S., Kammerer, W. A., Quezado, Z., Luckenbaugh, D. A., Salvadore, G., et al. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.90 · Cited by 963
Self-citation
Research works printed but not linked: 12
- Toljan K, 2018, Med Sci (Basel), 6, 82
- Lin F, 2015, Int J Clin Exp Med, 8, 4335
- Szarmach J, 2019, Psychiatr Danub, 31, 585
- Andrade C, 2019, J Clin Psychiatry, 80, 19f12820
- Canuso CM, 2019, Focus Am Psychiatr Publ, 17, 55
- Wei YB, 2013, Hong Kong Med J, 19, 341
- Morgan CJA, 2004, Psychopharmacology (Berl), 172, 298
- Health Quality Ontario, 2016, Ont Health Technol Assess Ser, 16, 1
- Rodrigues NB, CNS Spectr
- Ng J, Psychopharmacology (Berl)
- Rodrigues NB, CNS Spectr
- Lipsitz O, CNS Spectr
Cited by
Sorted by citations
Items 601–700 of 730
Research Progress of Esketamine in Improving Perioperative Depression and Sleep Quality
高, 永. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1472116
Treatment Resistant Depression, Ketamine versus ECT
Agarkar, S. (2024) · Open Journal of Psychiatry · doi:10.4236/ojpsych.2024.144023
Assessing the Efficacy of Methods for Treatment-Resistant Depression: A Review
Crisan, Z. (2024) · Journal of Student Research · doi:10.47611/jsrhs.v13i1.6275
Uso da cetamina na depressão resistente ao tratamento: uma revisão sistemática
Bessa, L. A., de Almeida, A. S., Andrade, V. A. D. O., Lira, R. M., & Matos, L. N. (2024) · Journal Archives of Health · doi:10.46919/archv5n3espec-522
Tavares, R. F., de Araújo, A. V., Silva, B. C., & Neto, R. C. B. D. F. (2024) · Revista Ibero-Americana de Humanidades, Ciências e Educação · doi:10.51891/rease.v10i8.15384
Machado‐Vieira, R., Jones, G. H., Courtes, A. C., Ruiz, A. C., Vecera, C. M., Henter, I. D., Lane, S. D., Zarate, C. A., & Soares, J. C. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.183
Self-citationAlmeida, T. M., Rosa, D. A. A., Pinheiro, T. B., Grilo, L. B., Jorge, G. M. T., Foletto, L. D., Generoso, I. P., da Silva, U. R. L., Uchida, R. R., & Cordeiro, Q. (2024) · Psychiatry Research Communications · doi:10.1016/j.psycom.2024.100190
Guo, T., Feng, Y., Zhou, J., Meng, L., Zhu, X., Xu, C., Xiao, L., Feng, L., Zhang, L., Xiang, Y., et al. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s462884
Hwang, M., & Brady, R. O. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20240741
Gillespie, C. F., & Nemeroff, C. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00046-7
Self-citationEscetamina no tratamento da depressão resistente: revisão de literatura
VALE, C. D. F. P. C. D. L., de Oliveira, L. S., Costa, H., Melo, I. A. D., Veras, J. V. M., de Medeiros, M. C. F., & Magalhães-Padilha, D. M. (2024) · RAMB Revista da Associação Médica Brasileira Junior Doctors · doi:10.5327/2965-0682-20245205
Gibfried, M., & Grossberg, G. T. (2024) · Cambridge University Press eBooks · doi:10.1017/9781108630344.017
Patarroyo-Rodríguez, L., Voort, J. L. V., Kung, S., Brown, S. K., Cavalcanti, S., Ritter, M. J., & Singh, B. (2024) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001939
Chapter 16. Organ Transplantation
(2023) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375264.lg16
Ketamine, from Anaesthetic to Drug Abuse
Guevara, M. A., Barrutieta-Arberas, I., Romanowicz, E. A., Haralanova, E., Haralanov, S., MARTINEZ, G., Llano, L. H., Gargiulo, Á. J. M., Gargiulo, A. P. Í., Colombini, A. P., et al. (2024) · Springer eBooks · doi:10.1007/978-3-031-72219-6_29
Wilkowska, A., & Cubała, W. J. (2025) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-025-01958-5
Novel Approaches for Treating Depression
Nestler, E. J., Charney, D. S., Krystal, J. H., & Murrough, J. W. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197640654.003.0035
Self-citationBack, M. S., Santiago, P. R. B., & Pellin, G. M. (2025) · Revista Contemporânea · doi:10.56083/rcv5n2-072
Dutra, R. N., Nascimento, M. V. F., Gontijo, J. P. S., LISBOA, K. S., Viana, G. F., Coelho, N. C., Dutra, S. M., & Alves, B. D. M. L. (2025) · STUDIES IN HEALTH SCIENCES · doi:10.54022/shsv6n1-037
Glutamatergic Changes Induced by Stress in the Brain and Effects of Rapid-Acting Antidepressants
Mingardi, J., & Musazzi, L. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_35-1
Pompili, M., Berardelli, I., Erbuto, D., & Caraci, F. (2025) · Annals of General Psychiatry · doi:10.1186/s12991-025-00549-x · Cited by 1
Supervised Machine-Learning Classification of Treatment-Resistant Depression in U.S. Claims DataPreprint
Wing, V. K., Lerner, J., Clarke, P., O’Connor, S. J., Tran, S., Darer, J. D., Gill, J. S., & Orsini, L. S. (2025) · medRxiv · doi:10.1101/2025.03.26.25324691
Pary, R., & Lippmann, S. (2025) · Southern Medical Journal · doi:10.14423/smj.0000000000001810 · Cited by 1
Challenges in management of treatment-resistant depression
Piech, G. M., & Lis, I. (2024) · Biuletyn Głównej Biblioteki Lekarskiej · doi:10.2478/bgbl-2024-0032
Benicio, L. A. D. O., da Silva, J. C. P., Bertazo, M. M., Roma, T. M., del Corsso, C., Alves, A. C., da Silva, J. A. L., Vieira, A. D., Barraza, J. P. P., MOREIRA, J. D., et al. (2025) · Caderno Pedagógico · doi:10.54033/cadpedv22n7-044
Ramm, R., Wiisanen, M., & DeMarco, M. (2025) · Psychedelics in Palliative Care · doi:10.1093/med/9780197760864.003.0005
Shou, Y.-H., Luo, J.-S., Zhang, X., Zhai, W.-H., & Han, J. (2025) · International journal of anesthesia and clinical medicine. · doi:10.11648/j.ijacm.20251301.16
Investing in Group Psychedelic Therapy for Latinx Immigrants
Zambrano, J., Forcén, F. E., Hidalgo, J., & King, F. (2025) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-025-01702-0
No Laughing Matter: Nitrous Oxide and Depression
Williams, E., & Cowen, P. J. (2025) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2025.100551
Beydler, E. M., Katzell, L. M., Dragonetti, J. D., & Ortiz, N. (2025) · Journal of Ect · doi:10.1097/yct.0000000000001173
Saudemont, G., Brunet-Jailly, J., & Coz, P. L. (2025) · Éthique & Santé · doi:10.1016/j.etiqe.2025.06.001
Treatment of pharmacoresistant states in psychiatry. Part 2: Treatment-resistant depression
Češková, E. (2025) · Psychiatrie pro praxi · doi:10.36290/psy.2025.015
Anesthetic Amnesia: The Forgotten Importance of Forgetting?
Pryor, K. O., Jiang, Y., & SLEIGH, J. W. (2025) · Anesthesiology · doi:10.1097/aln.0000000000005544
Dines, M., Bulacia, A. V., Bamondez, P., Vega, I. L., Montenegro, M., Díaz, P. G., Oyhamburu, P., Ramos, A. L., Ambrosio, F., Vázquez, G. H., et al. (2025) · Vertex Revista Argentina de Psiquiatría · doi:10.53680/vertex.v36i168.832
Zaremba, M., & Kleczkowska, P. (2025) · Neuromethods · doi:10.1007/978-1-0716-4599-4_17
Managing treatment-resistant depression in the setting of chronic pain
Mohammad, A. S. A., & Parikh, S. V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00032-3
Ketamine/esketamine for treatment-resistant depression
Nikayin, S., & Sanacora, G. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00013-x · Cited by 3
Self-citationRalphs, R., Day, J., & Dewhurst, J. (2025) · Addiction · doi:10.1111/add.70181
Glutamatergic Changes Induced by Stress in the Brain and Effects of Rapid-Acting Antidepressants
Mingardi, J., & Musazzi, L. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_35
Hack, L. M., Zhang, X., & Williams, L. M. (2025) · Neuromethods · doi:10.1007/978-1-0716-4603-8_12
Neurophysiological Markers of (Dis)Connectedness: Insights from Ketamine
Alnagger, N., Cardone, P., Montupil, J., Annen, J., Martial, C., Bonhomme, V. L., & Gosseries, O. (2025) · Neuromethods · doi:10.1007/978-1-0716-4603-8_8
Use of Esketamine NS in Treatment-Resistant Depression/Gambling Disorder Comorbidity
Lupi, M., Carano, A., Acciavatti, T., Carlucci, M. C., Berardis, D. D., & Martinotti, G. (2025) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002098
Ketamine for depression and other psychiatric diseases
Roth, W. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29930-8.00005-9
Ketamine for neuropathic pain: Animal and human studies
Dahan, A., Niesters, M., Sarton, E. Y., & van Velzen, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29930-8.00016-3
Overlap and Divergence in Ketamine and Lithium Response in Bipolar Disorder: A Scoping Review
Toulany, J., Cunningham, J. E. A., & Nunes, A. (2025) · Pharmaceuticals · doi:10.3390/ph18111662
Ketamine and its Regulatory Implications: A Review
Soin, A., Reddy, Y., Ferguson, K., Flores, R. A., Tsirulnikov, Y., Davis, C., Lewis, M. C., Root, J. R., & Mandava, A. (2025) · Journal of Medical Regulation · doi:10.30770/2572-1852-111.3.41
Xie, J.-X., & Zhou, L.-W. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11357-7
MODERN STRATEGIES FOR THE TREATMENT OF TREATMENT-RESISTANT DEPRESSION – A LITERATURE REVIEW
Rożek, I., Gąska, W., Lekan, I., Mazurek, J., Brzezińska, A., Tuszyńska, W., Sodolska, A., Lenart, M., Madoń, B., & Teresińska, B. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3822
The mtDNA-cGAS-STING pathway: linking neuroinflammation and Alzheimer’s disease
Guan-Lin, H. E., HUANG, Z.-B., & Guang, L. U. (2025) · Scientia Sinica Vitae · doi:10.1360/ssv-2025-0049
黄, 晔. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15123391
Xie, J.-X., Wang, X., Li, Y., Zhang, Y., Liu, T., Liu, M., Liu, J., & Zhou, L.-W. (2025) · Pain and Therapy · doi:10.1007/s40122-025-00809-4
( S )-ketamine augments behavioral and physiological responses to Δ 9 -tetrahydrocannabinolPreprint
Keimpema, E., Vigl, V., Torgasheva, N., Romanov, R. A., Kasper, S. F., & Harkany, T. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.18.695060
Self-citationAtasoy-Rodriguez, I. L., Johnson, K. W., Patel, K., Arain, H., Zaidi, S., Herold, K. F., Milner, T. A., Hemmings, H. C., & Platholi, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.02.697407
Report from the WPA Section on Suicidology: recent advances and activities
Carli, V., Sütöri, S., & Iosue, M. (2026) · World Psychiatry · doi:10.1002/wps.70038
Eckert, D., & Kasper, S. F. (2026) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2026.2617195 · Cited by 1
Self-citationYoon, S. (2026) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/ceog45609
Kosted, R., Waddell, A., Adolph, K., & Fonzo, G. A. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121350
McNaughton, N., Shadli, S. M., Beaglehole, B., & Glue, P. (2026) · Journal of the Royal Society of New Zealand · doi:10.1002/snz2.70002
Menon, T., Lu, A., Arulmozhi, A., Dri, C., Wong, S., Teopiz, K., Le, G.-H., Lee, S., Weissman, C. R., & McIntyre, R. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117036 · Cited by 1
Self-citationgao, J., Dai, L., Qin, L., Duan, B., Peng, D., Huang, X., He, L., Zou, J., Zhou, Q., & Zhou, D. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1722131
Zhou, M., Qi, Y., Zhou, F., Wu, H., Chen, J., Wang, L., & Wang, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1746121
Lees, T., Scott, J. N., Boyle, B. W., Esfand, S. M., Linton, S. R., Miller, C., Li, M., Woronko, S. E., Dunayev, R., Bogdanov, M., et al. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03928-4
Wu, J., Zou, Y., Zhou, J., Meng, F., & Xiao, L. (2026) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s579440
Effects of esketamine combined with QLB in older frail patients with colorectal cancer surgery
Dai, S., Wang, L. Y., Zhang, K., Wang, R., Li, N., & Zhang, X. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1749820
Shu, Y., Guo, Y., Xu, S., He, H., Zeng, B., Yang, Z., Gao, W., & Li, J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0343918
Dong, Y., Cui, Y., He, J., & Yu, P. (2026) · Global Medical Education · doi:10.1515/gme-2025-0010
Zeng, Z. (2026) · Research Square · doi:10.21203/rs.3.rs-9045317/v1
Atídio, J. P., Delfino, R. S., Garios, I. S., de Brito, C. S. G. F., Gerheim, Y. P., Vasconcelos, G. M. D. A. E., Piloto, R., Ferro, M. D., Júnior, R. O. P. D. S., Surjan, J. C., et al. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.121721
Duncan, E., Hersant, H., & Khairova, R. A. (2026) · Springer eBooks · doi:10.1007/978-3-032-15772-0_4
Caractérisation neuro-computationnelle de l'humeur : causes et conséquences
Carrillo, P. (2024) · theses.fr (ABES) · doi:10.70675/181aec0cz429dz4bccz83f0za479cbef52f7
Lii, T. R., Sikka, P., Deverett, B., Altirkawi, O. K., & Heifets, B. D. (2026) · Pain Management · doi:10.1080/17581869.2026.2658080
Viniegra, J. P. B. (2026) · Cureus · doi:10.7759/cureus.107343
Carmellini, P., Cuomo, A., Rescalli, M. B., Pinzi, M., Dourmas, A., & Fagiolini, A. M. (2026) · Pharmaceuticals · doi:10.3390/ph19050662
Fagan, H. A. (2026) · The British Journal of Psychiatry · doi:10.1192/bjp.2026.10635
Psychedelics: Future Therapeutics in Major Depression?
Olivier, B., & Olivier, J. D. A. (2026) · Advances in experimental medicine and biology · doi:10.1007/978-981-95-6872-7_25
Intranasal Ketamine for Existential Distress in Advanced Cancer
Aguiar, S., Makarious, M., Lipsitz, O., deVries, F. E., Doyle, Z., McIntyre, R. S., Rodin, G., Zimmermann, C., Mak, E., Hannon, B. L., et al. (2026) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2026.04.611 · Cited by 1
Self-citationLunsky, I. O., Gutierrez, G., Wang, X., Zhuang, A., Zhang, Y., Vázquez, G. H., Bhat, V., Archer, S., Khullar, A., Chrenek, C., et al. (2026) · Psychiatry Research · doi:10.1016/j.psychres.2026.117221 · Cited by 1
Sunzeri, F. (2026) · Springer eBooks · doi:10.1007/978-3-032-14465-2_16
Kwaśny, A., Wilkowska, A., Pastuszak, M., Pastuszak, K., & Cubała, W. J. (2026) · Pharmacological Reports · doi:10.1007/s43440-026-00867-1
Wasolua, T. T., Bommersbach, T. J., McIntyre, R. S., & Rhee, T. G. (2026) · Research Square · doi:10.21203/rs.3.rs-9827580/v1
Self-citationQu, Y., Li, S., Tian, L., Tian, X., & Wu, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1792570
Chapter 10. Transcranial Magnetic Stimulation: Recent and Future Innovations
Cook, I. A., Bermudes, R. A., & Janicak, P. G. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894550671.lg10
Yakovleva, O. B., Сафарова, Т. П., & Savushkina, O. K. (2026) · Psikhiatriya · doi:10.30629/2618-6667-2026-24-2-15-27
Prescribing bias and adverse outcomes of esketamine in major depression comorbid substance
Li, D., Hsu, T.-W., Changchien, T.-C., Fang, Y.-Y., Yang, F.-C., Lin, H., & Liang, C.-S. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122106
Montero, A. A. (2026) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.sjpmh.2026.03.007
THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRY
Osipowska, J., Kwolek, M., Judzińska, A., Piech, B., Sobczyńska, K., Ignarska, J., Terbosh, M., `Mzabi, S. K., Trojanowska, E., & Dubaj, M. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5605
Wong, S., Le, G. H., Zheng, Y. J., Guillen-Burgos, H. F., Dri, C. E., Teopiz, K. M., & McIntyre, R. S. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122156
Self-citationGrygutis, I., Mikołajczyk, O., Fimiarz, K., Jarzęcka, U., Łysak, K., Pawełkiewicz, S., Wójcik, K., Serafin, A., Baran, K., & Podolak, M. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5567
Choo, T.-H. J., Galfalvy, H., Keilp, J. G., Burke, A. K., MANN, J., & Grunebaum, M. F. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122175
Schuman, H. D. M., Mina, R., Barkova, S., Nguyen, T., Deleemans, J. M., & Carlson, L. E. (2026) · Global Advances in Integrative Medicine and Health · doi:10.1177/27536130261459354
BEYOND AESTHETICS: BOTULINUM TOXIN TYPE A AS AN EMERGING ANTIDEPRESSANT STRATEGY
Dutkiewicz, D., Kowalski, J., Yarbou, A. E., Mallah, R., Kozdroń, D. J., Nieścioruk, M. W., Szczepańska, P., Tokarczyk, M., & Samujilik, A. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.2(50).2026.5358
Bellanti, P. A., Lewis, J., Seifferth, B., & Adams, D. Z. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1867963
Curtis, K., Muere, A., Robertson, E., Bains, V., Alvares, D., Kalleitner, A., Peng, P., Tumber, P., Baig, E., Hoydonckx, Y., et al. (2026) · Pain Management · doi:10.1080/17581869.2026.2696883
Dissociation and antidepressant response to subcutaneous esketamine: A clinical study
Gonçalves, K. T. D. C., Tavares, V. D. D. O., Palhano-Fontes, F., Cavalcanti-Ribeiro, P., de Almeida, V. R. N., Barbosa, D. C., Fernandes, T. U. G., Cardoso, E. I. T., Lima, N. B. D. M., de Brito, A. J. C., et al. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.07.016
Yang, J., Huang, T., Wang, M., Yingrui, X., Xuan, L., Li, C., Cao, W., Liyan, H., & Zhou, H. M. (2026) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2026.07.016
Hepatic Safety of Ketamine and Esketamine for Treatment-Resistant Depression
Singh, B., Leung, J. G., Pazdernik, V., Kung, S., & Voort, J. L. V. (2026) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002228
McIntyre, R. S. (2026) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2026.07.014
Self-citationA crucial cautionary note on frequently incorrect dose equivalence between ketamine and esketamine
Damiano, R. F., Medeiros, G. C., & Quevedo, J. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03807-w
Sierra, P., Cañada, Y., Benavent, P., Sabater, A., de la Fuente, E., & García‐Blanco, A. (2026) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2026.105110
Metadata
- Authors
- McIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., Iosifescu, D. V., Lopez Jaramillo, C., Kasper, S., Kratiuk, K., Lee, J. G., Lee, Y., Lui, L. M. W., Mansur, R. B., Papakostas, G. I., Subramaniapillai, M., Thase, M., Vieta, E., Young, A. H., Zarate, C. A., & Stahl, S.
- Affiliations
- University Health Network (CA)
- Mood Disorders Psychopharmacology Unit, University Health Network, Toronto (McIntyre, Rosenblat, Y. Lee, Lui, Mansur); Department of Psychiatry, University of Toronto, Toronto (McIntyre, Rosenblat, Mansur); Department of Pharmacology, University of Toronto, Toronto (McIntyre); Brain and Cognition Discovery Foundation, Toronto (McIntyre, Subramaniapillai); Canadian Rapid Treatment Center of Excellence, Mississauga, Ontario (Rosenblat, Kratiuk); Department of Psychiatry and Behavioral Sciences, Austin Dell...
- ORCID
- McIntyre, Roger S.
- Rosenblat, Joshua D.
- Nemeroff, Charles B.
- Sanacora, Gerard
- Murrough, James W.
- Brietzke, Elisa
- Dodd, Seetal
- Gorwood, Philip
- Ho, Roger
- Iosifescu, Dan V.
- Kasper, Siegfried
- Kratiuk, Kevin
- Lee, Jung Goo
- Lee, Yena
- Lui, Leanna M.W.
- Mansur, Rodrigo B.
- Papakostas, George I.
- Subramaniapillai, Mehala
- Thase, Michael
- Vieta, Eduard
- Young, Allan H.
- Zarate, Carlos A.
- Stahl, Stephen
- Venue
- American Journal of Psychiatry
- Published
- 2021-05-01
- Volume
- 178
- Issue
- 5
- Pages
- 383-399
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- PMC
- PMC9635017
- OpenAlex
- W3137976016
- Semantic Scholar
- 3cd087ef6947b39c8c924b7248d9d40de77b9e44
- Cited by
- 731
- References
- 168
- Citations by year
- 2026: 129 · 2025: 167 · 2024: 165 · 2023: 141 · 2022: 83 · 2021: 44
- FWCI
- 13.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- National Institute for Health and Care Research (NIHR202380)
- National Institutes of Health (Z99 MH999999)
- National Institute of Mental Health (ZIAMH002857, ZIAMH002927)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- ketamine, esketamine, treatment-resistant depression, major depressive disorder, drug safety and tolerability, clinical implementation, treatment algorithm, expert consensus
- MeSH terms
- Implementation Science, Antidepressive Agents, Delivery of Health Care, Depressive Disorder, Major, Major Depressive Disorder, Dissociative Disorders, Humans, Hypertension, Ketamine, Monitoring, Physiologic, Personnel Staffing and Scheduling, Psychoses, Substance-Induced, Patient Selection, Excitatory Amino Acid Antagonists, Substance-Related Disorders, Suicidal Ideation, Lower Urinary Tract Symptoms, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
